| PUBCHEM ID |
29969962
|
| UNII |
2630IZQ0I0
|
| Preferred Term |
ABACAVIR 5'-.BETA.-D-GLUCURONIDE
|
| CAS |
384329-76-4
|
| INCHIKEY |
WGTDUQBKKUUVMK-OLMRCODSSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
Nc1nc(NC2CC2)c2ncn([C@@H]3C=C[C@H](CO[C@H]([C@H]([C@@H]([C@H]4O)O)O)O[C@H]4C(O)=O)C3)c2n1
|
| Total Surface Area |
317,51
|
| Relative PSA |
0,47857
|
| TPSA |
198,1
|
| cLogS |
-2,68
|
| MW |
462,461
|
| cLogP |
-1,7969
|
| H-Acceptors |
13
|
| H-Donors |
6
|
| Ro5 violations |
2
|
| Druglikeness |
2,0963
|
| DrugScore |
0,726831979576802
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,0279
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Nucleus
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Non-substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,1677
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5382
|
| Tetrahymena Pyriformis Toxicity |
Low HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,5103
|
| Carcinogenicity (Three-class) |
Non-required
|